We are live on ! Find out more
TSHA icon

Taysha Gene Therapies
TSHA

46 hedge funds and large institutions have $358M invested in Taysha Gene Therapies in 2021 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.89% less ownership

Funds ownership: 47.67% → 46.77% (-0.89%)

10% less funds holding

Funds holding: 51 → 46 (-5)

25% less capital invested

Capital invested by funds: $475M → $358M (-$117M)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
46
Holders Change
-5
Holders Change %
-9.8%
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
17
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$8.65M
2
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
+$4.85M
3
Wells Fargo
Wells Fargo
California
+$1.22M
4
BlackRock
BlackRock
New York
+$851K
5
DC
Davenport & Co
Virginia
+$546K

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$10.4M
2
DM
Deerfield Management
New York
-$6.63M
3
Sands Capital Management
Sands Capital Management
Virginia
-$2.59M
4
NCM
Nantahala Capital Management
Connecticut
-$1.13M
5
Citadel Advisors
Citadel Advisors
Florida
-$949K
Name Holding Trade Value Shares
Change 		Change in
Stake
Alyeska Investment Group
26
Alyeska Investment Group
Illinois
$508K -$677K -25,000 -50%
Morgan Stanley
27
Morgan Stanley
New York
$466K -$227K -8,377 -27%
Millennium Management
28
Millennium Management
New York
$429K +$46.7K +1,725 +9%
DC
29
Davenport & Co
Virginia
$409K +$546K +20,150 New
N
30
Nuveen
North Carolina
$357K +$91.3K +3,373 +24%
Bank of America
31
Bank of America
North Carolina
$301K +$225K +8,299 +127%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$266K – – –
HF
33
HRT Financial
New York
$248K +$331K +12,239 New
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$179K +$106K +3,900 +80%
Deutsche Bank
35
Deutsche Bank
Germany
$119K -$6.42K -237 -4%
SO
36
STRS Ohio
Ohio
$42K – – –
CAPTRUST Financial Advisors
37
CAPTRUST Financial Advisors
North Carolina
$20K +$6.53K +241 +33%
Legal & General Group
38
Legal & General Group
United Kingdom
$18K – – –
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$18K +$11K +406 +87%
AIP
40
Ameritas Investment Partners
Nebraska
$15K – – –
TRCT
41
Tower Research Capital (TRC)
New York
$13K +$9.02K +333 +114%
Citigroup
42
Citigroup
New York
$12K -$28.1K -1,038 -64%
RE
43
RBC Europe
United Kingdom
$5.08K – – –
Bank of Montreal
44
Bank of Montreal
Ontario, Canada
$5K -$29.7K -1,096 -80%
Osaic Holdings
45
Osaic Holdings
Arizona
$5K +$6.53K +241 New
AIG
46
American International Group
New York
$103 +$379 +14 +0.3%
APM
47
Avidity Partners Management
Texas
– -$10.4M -392,000 Closed
DM
48
Deerfield Management
New York
– -$6.63M -250,000 Closed
Citadel Advisors
49
Citadel Advisors
Florida
– -$949K -35,752 Closed
CCM
50
CAAS Capital Management
New York
– -$796K -30,000 Closed
1
2
3

TSHA Hedge Fund Activity: Q1 2021 in Review

46 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Taysha Gene Therapies (TSHA) for Q1 2021, worth a combined $358M — down 25% from $475M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of TSHA and 3 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 17 added.

The largest buyer was Franklin Resources, adding an estimated $8.65M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $10.4M sold.

  • 46 institutional investors held Taysha Gene Therapies (TSHA) as of Q1 2021, down from 51 in Q4 2020.
  • Funds reported $358M of Taysha Gene Therapies stock for Q1 2021, down 25% quarter-over-quarter.
  • 3 funds opened new Taysha Gene Therapies positions in Q1 2021 and 8 closed out, a net change of -5 holders.
  • The largest Taysha Gene Therapies buyer in Q1 2021 was Franklin Resources, an estimated $8.65M added.
  • The largest Taysha Gene Therapies seller in Q1 2021 was Avidity Partners Management, an estimated $10.4M sold.

Based on aggregated 13F filings for Q1 2021.